What is the most common cause of death among patients undergoing hemodialysis (HD) for end-stage renal disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Most Common Cause of Death in Hemodialysis Patients

Cardiovascular disease is the most common cause of death among hemodialysis patients, accounting for approximately 40-50% of all deaths in this population, with infections being the second leading cause. 1, 2

Primary Cause: Cardiovascular Disease

The evidence consistently demonstrates that cardiovascular disease dominates mortality in the hemodialysis population:

  • Cardiovascular disease accounts for at least 40% of deaths in end-stage renal failure patients, with some studies reporting up to half of all deaths attributed to cardiovascular causes including coronary heart disease, cerebrovascular disease, peripheral vascular disease, and heart failure 2, 3, 4

  • The risk of cardiovascular death is approximately 30 times higher in hemodialysis patients compared to the general population, and remains 10-20 times higher even after adjusting for age, gender, and diabetes 3, 4

  • Cardiac diseases are by far the most common cause of cardiovascular deaths in dialysis patients, justifying their prominent focus in clinical guidelines 2

Secondary Cause: Infections

While cardiovascular disease leads, infections represent the second most important cause of mortality:

  • Infections remain a leading cause of death, second only to cardiovascular disease, according to the most recent 2020 American Journal of Kidney Diseases guidelines 1

  • Infections account for a major share of hospitalizations in addition to mortality in this patient population 1

Specific Cardiovascular Mechanisms

The cardiovascular mortality burden manifests through several specific mechanisms:

  • Sudden cardiac death (SCD) is the leading cause of death within the cardiovascular category, accounting for death in up to one-quarter of the entire hemodialysis population 5

  • Nearly half of deaths on dialysis are secondary to myocardial infarction, cardiac arrest, malignant arrhythmias and other cardiac causes 6

  • Left ventricular hypertrophy is present in almost 80% of dialysis patients, serving as a substrate for both systolic and diastolic dysfunction 7

  • Approximately 31% of patients have heart failure at dialysis initiation and an additional 25% develop it during their course on dialysis, making it one of the most prevalent cardiovascular complications 7

Clinical Context and Timing

Understanding when cardiovascular deaths occur helps inform prevention strategies:

  • The most common times for sudden cardiac death are toward the end of the long 72-hour weekend interval between dialysis sessions and in the 12 hours immediately after hemodialysis 5

  • The dialysis procedure itself may have important implications for sudden cardiac death, as hemodialysis is associated with both ventricular arrhythmias and dynamic electrocardiographic changes 5

Hospitalization Patterns

Cardiovascular disease also drives the majority of hospitalizations:

  • Cardiovascular disease is the most frequent cause for hospitalizations among hemodialysis patients (33.68%), with coronary heart disease (37.26%) and heart failure (14.51%) being the most common specific conditions 8, 9

Important Caveats

Traditional cardiovascular risk stratification tools from the general population are inadequate when assessing hemodialysis patients because coronary artery disease and heart failure often are not the underlying pathologic processes for sudden cardiac death in this population 5. Factors assuming greater importance include left ventricular hypertrophy, electrolyte shifts, and vascular calcification 5.

References

Research

Sudden cardiac death in hemodialysis patients: an in-depth review.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011

Research

Arrhythmias in hemodialysis patients.

Journal of nephrology, 2009

Guideline

Heart Failure in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Factors That Worsen Kidney Disease Progression in Hospitalized Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Annual Mortality Rate for Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

In a 61-year-old male with end-stage renal disease on hemodialysis, a history of paroxysmal atrial fibrillation status post catheter ablation, currently in sinus rhythm with a resting heart rate of 62 bpm, off beta‑blocker, on chronic warfarin (with easy bruising) and amiodarone 200 mg daily, is cardioversion indicated?
How do I manage tachycardia in a patient with End-Stage Renal Disease (ESRD)?
In a female patient with end‑stage renal disease on chronic hemodialysis, uncontrolled hypertension, atrial fibrillation/flutter, type 2 diabetes, chronic hypoxia, and recent interruption of dialysis, who presents with a blood pressure of 203/108 mm Hg, chest tightness, palpitations, nausea, vomiting, and left‑sided headache, is this a hypertensive urgency or a hypertensive emergency?
What is the most likely cause of sudden respiratory and cardiac arrest in an end‑stage renal disease patient after two hours of hemodialysis when initial labs, electrocardiogram, and brain CT are normal?
What is the differential diagnosis for palpitations in a female patient with end‑stage renal disease on chronic hemodialysis, uncontrolled hypertension, atrial fibrillation/atrial flutter (non‑adherent to apixaban), type 2 diabetes mellitus, chronic hypoxia on home oxygen, and a recent interruption of dialysis?
What is the role of aspirin (acetylsalicylic acid) in managing secondary polycythemia vera, particularly in patients with underlying conditions such as chronic obstructive pulmonary disease (COPD) or sleep apnea?
What tests are recommended to determine cardiovascular risk in patients with End-Stage Renal Disease (ESRD) undergoing dialysis?
What is the staging and treatment approach for a patient with breast cancer and a focal lesion involving the sternum?
What alternative antibiotic regimen can be used for a patient with septic arthritis due to meningococcal infection who is not responding to initial treatment with ceftriaxone (Ceftriaxone) or cefotaxim (Cefotaxime), considering the use of meropenem (Meropenem)?
What is the normal flow rate in an arteriovenous (AV) fistula for a patient with end-stage renal disease (ESRD) undergoing dialysis?
How does the anti-Glutamic Acid Decarboxylase (GAD) antibody test work in patients with suspected autoimmune disorders?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.